Borgeson Blake sold RXRX

March 3, 2026 · Form 4 insider transaction

Borgeson Blake sold 170,000 shares of Recursion Pharmaceuticals, Inc. at $3.46 per share, a transaction worth $588.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.